| 000 | 01832 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518023656.0 | ||
| 264 | 0 | _c20190827 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1878-3511 | ||
| 024 | 7 |
_a10.1016/j.ijid.2019.02.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTimire, Collins | |
| 245 | 0 | 0 |
_aAccess to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain _h[electronic resource] |
| 260 |
_bInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases _cApr 2019 |
||
| 300 |
_a236-243 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDiagnostic Tests, Routine |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluoroquinolones _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 |
_aRifampin _xtherapeutic use |
| 650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdiagnosis |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 | _aZimbabwe |
| 700 | 1 | _aSandy, Charles | |
| 700 | 1 | _aKumar, Ajay M V | |
| 700 | 1 | _aNgwenya, Mkhokheli | |
| 700 | 1 | _aMurwira, Barbara | |
| 700 | 1 | _aTakarinda, Kudakwashe C | |
| 700 | 1 | _aHarries, Anthony D | |
| 773 | 0 |
_tInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases _gvol. 81 _gp. 236-243 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijid.2019.02.007 _zAvailable from publisher's website |
| 999 |
_c29384826 _d29384826 |
||